Synthetic organic

BD-1063.

BD-1063.

InformationBDTX-189 is a potent and selective inhibitor of allostericEGFRandHER2oncogenic mutations with Kd of 0.2 nM, 0.76 nM, 13 nM and 1.2 nM for EGFR, HER2,BLKandRIPK2, reapectively. BDTX-189 exhibits anticancer activity.TargetsEGFR (Cell-free

InformationBDTX-189 is a potent and selective inhibitor of allostericEGFRandHER2oncogenic mutations with Kd of 0.2 nM, 0.76 nM, 13 nM and 1.2 nM for EGFR, HER2,BLKandRIPK2, reapectively. BDTX-189 exhibits anticancer activity.TargetsEGFR (Cell-free

InformationBDTX-189 is a potent and selective inhibitor of allostericEGFRandHER2oncogenic mutations with Kd of 0.2 nM, 0.76 nM, 13 nM and 1.2 nM for EGFR, HER2,BLKandRIPK2, reapectively. BDTX-189 exhibits anticancer activity.TargetsEGFR (Cell-free

InformationBDTX-189 is a potent and selective inhibitor of allostericEGFRandHER2oncogenic mutations with Kd of 0.2 nM, 0.76 nM, 13 nM and 1.2 nM for EGFR, HER2,BLKandRIPK2, reapectively. BDTX-189 exhibits anticancer activity.TargetsEGFR (Cell-free

Beclometasone dipropionate is a potent glucocorticoid agonist: it is a prodrug of the free form, beclometasone.A corticosteroid.

Beclometasone dipropionate is a potent glucocorticoid agonist: it is a prodrug of the free form, beclometasone.A corticosteroid.

Beclometasone dipropionate is a potent glucocorticoid agonist: it is a prodrug of the free form, beclometasone.A corticosteroid.

Beclometasone dipropionate is a potent glucocorticoid agonist: it is a prodrug of the free form, beclometasone.A corticosteroid.

BED.

BED.